Clinicopathological factors and mucin expression in the primary lesions for each patient in the recurrence group
| Case | Age (years) | Sex | Site | Size (cm)* | Margin† | Capsular invasion | Tumour variant‡ | Mucin expression | Recurrence | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MUC1 | MUC2 | MUC4 | MUC5AC | MUC6 | |||||||||||||
| CORE | DF3 | MY.IE12 | Glycoprotein | HMFG-1 | |||||||||||||
| *Maximum diameter; †+, incomplete surgical resection; −, complete surgical resection microscopically; ‡A, stroma rich variant; B, intermediate, C, stroma poor variant. | |||||||||||||||||
| The positively stained neoplastic cells were graded as follows: −, less than 5% of neoplastic cells stained; +, more than 5% but less than 30% of neoplastic cells stained; ++, more than 30% of neoplastic cells stained. | |||||||||||||||||
| SM, submandibular. | |||||||||||||||||
| 1 | 35 | F | Palate | 4.5 | + | + | A | − | − | − | − | − | − | − | − | − | 1st (3y), 2nd (5y) |
| 3rd (9y), 4th (12y) | |||||||||||||||||
| 2 | 32 | M | Parotid | 2.2 | + | − | A | − | − | − | − | − | − | − | − | − | 1st (7y) |
| 3 | 27 | M | Parotid | 4.0 | − | − | A | − | − | − | + | − | + | − | + | + | 1st (4y) |
| 4 | 62 | F | Parotid | 2.0 | + | + | A | − | + | − | + | − | − | − | − | + | 1st (5y), 2nd (13y) |
| 5 | 60 | F | Parotid | 4.5 | + | − | C | − | ++ | − | − | + | − | − | − | − | 1st (11y) |
| 6 | 53 | M | Parotid | 3.0 | − | + | A | − | + | + | − | − | − | − | + | + | 1st (8y) |
| 7 | 50 | M | Parotid | 3.0 | − | − | A | + | ++ | ++ | ++ | − | − | − | − | + | 1st (4y) |
| 8 | 32 | F | SM | 4.0 | + | + | B | ++ | ++ | ++ | ++ | ++ | − | − | − | ++ | 1st (6y) |
| 9 | 38 | F | Parotid | 1.5 | − | + | B | + | ++ | + | + | − | − | − | − | − | 1st (10y) |